CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 146 filers reported holding CLOVIS ONCOLOGY INC in Q4 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $390,000 | -77.1% | 28,400 | -68.0% | 0.01% | -80.0% |
| Q1 2016 | $1,705,000 | +508.9% | 88,826 | +2817.1% | 0.03% | +1400.0% |
| Q3 2015 | $280,000 | -54.3% | 3,045 | -56.3% | 0.00% | -60.0% |
| Q2 2015 | $613,000 | -24.6% | 6,973 | -36.3% | 0.01% | -37.5% |
| Q1 2015 | $813,000 | +74.8% | 10,955 | +32.0% | 0.01% | +166.7% |
| Q4 2014 | $465,000 | -45.5% | 8,300 | -55.9% | 0.00% | -40.0% |
| Q3 2014 | $853,000 | -41.1% | 18,800 | -46.3% | 0.01% | -28.6% |
| Q2 2014 | $1,449,000 | +546.9% | 35,000 | +982.6% | 0.01% | +600.0% |
| Q1 2014 | $224,000 | -32.7% | 3,233 | -40.9% | 0.00% | -50.0% |
| Q3 2013 | $333,000 | – | 5,473 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |